Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention

Micaela Iantorno1, Toby Rogers2, Rebecca Torguson1

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.

Insights

Black women experienced higher rates of major adverse cardiovascular events after percutaneous coronary intervention (PCI). This study highlights racial disparities in cardiovascular outcomes, particularly stent thrombosis, in women undergoing PCI.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Disparities Research

Background:

  • Women, particularly Black women, are underrepresented in cardiovascular studies and face higher mortality risks from ischemic heart disease.
  • Limited data exists comparing outcomes for Black versus white women after percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate racial disparities in 1-year major adverse cardiovascular events (MACE) among women undergoing PCI.
  • To compare outcomes between Black and white women after PCI.

Main Methods:

  • Retrospective analysis of 4776 female patients (1916 Black, 2860 white) who underwent PCI between 2003 and 2016.
  • Endpoints included MACE, death, myocardial infarction, target vessel revascularization (TVR), and stent thrombosis (ST) at 30 days and 1 year.
  • Proportional Cox hazard models were used to assess outcomes after adjusting for confounding factors.

Main Results:

  • Black women presented younger with higher risk factor prevalence but had similar periprocedural/in-hospital outcomes.
  • Rates of myocardial infarction, TVR, and ST were significantly higher in Black women at 30 days and 1 year.
  • After adjustment, only stent thrombosis (ST) remained significantly higher in Black women compared to white women.

Conclusions:

  • Racial disparities exist in baseline characteristics and outcomes for women undergoing PCI, with Black women presenting later and experiencing higher rates of ST.
  • Interventions for early diagnosis and improved prevention are needed for Black women.
  • Further research should identify factors contributing to cardiovascular outcomes in women post-PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
199
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
319
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
937
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
280